Sensus Healthcare Inc SRTS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $2.97
- Day Range
- $2.93–3.04
- 52-Week Range
- $2.66–5.49
- Bid/Ask
- $2.91 / $3.02
- Shares Outstanding
- 16.46M
- Market Cap
- $48.56M
- Volume/Avg
- 13,226 / 29,074
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.76
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 60
- Website
- https://www.sensushealthcare.com
Valuation
|
Metric
|
SRTS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.32 |
Price/Sales | 2.76 |
Price/Cash Flow | — |
Price/Earnings
SRTS
Financial Strength
|
Metric
|
SRTS
|
|---|---|
Quick Ratio | 3.90 |
Current Ratio | 8.71 |
Interest Coverage | — |
Quick Ratio
SRTS
Profitability
|
Metric
|
SRTS
|
|---|---|
Return on Assets (Normalized) | −29.01% |
Return on Equity (Normalized) | −32.63% |
Return on Invested Capital (Normalized) | −33.24% |
Return on Assets
SRTS
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|XL&dB^? | LOCK|VY#&N | $172B | |||
| Medtronic PLC
MDT
| LOCK|<P@&^mY | LOCK|tD?Y | $113B | |||
| Stryker Corp
SYK
| LOCK|yvjp>zk | LOCK|^l# | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|?fQS&yR | LOCK|b>@G< | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|c%v$tCZ | LOCK|MqDP | $49B | |||
| DexCom Inc
DXCM
| LOCK|ffh>xkX> | LOCK|<h^< | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|G<^#K<@ | LOCK|Y! | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|HdB | LOCK|L%% | $24B | |||
| Steris PLC
STE
| LOCK|L?t^^& | LOCK|^@%Lp | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|g>>J$K< | LOCK|bP | $17B |
United States